Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Cash flows from operating activities    
Net income (loss) $ 57,746 $ 35,678
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Provision for loss on receivables 5,629 8,027
Depreciation and amortization 2,685 2,693
Amortization of financing costs 5,824 5,073
Equity-based compensation 11,615 10,385
Equity method investments 14,024 3,695
Non-cash gain on securitization (36,866) (18,575)
Gain on sale of receivables and investments 8,671 3,140
Changes in accounts payable and accrued expenses 5,906 (4,804)
Other (23,372) (13,726)
Net cash provided by (used in) operating activities 51,862 31,586
Cash flows from investing activities    
Equity method investments (322,948) (48,301)
Equity method investment distributions received 90,920 53,485
Proceeds from sales of equity method investments 0 8,433
Purchases of and investments in receivables (92,232) (274,472)
Principal collections from receivables 94,780 48,900
Proceeds from sales of receivables 52,329 134,932
Purchases of investments (22,777) (22,242)
Principal collections from investments 1,981 5,432
Proceeds from sales of investments and securitization assets 58,018 90,993
Funding of escrow accounts (7,783) (28,672)
Withdrawal from escrow accounts 6,300 29,156
Other 3,200 2,891
Net cash provided by (used in) investing activities (138,212) 535
Cash flows from financing activities    
Proceeds from credit facilities 126,000 101,500
Principal payments on credit facilities (134,594) (321,869)
Proceeds from issuance of non-recourse debt 15,938 34,988
Principal payments on non-recourse debt (118,623) (180,708)
Proceeds from issuance of senior unsecured notes 771,250 507,313
Proceeds from issuance of convertible notes 143,750 0
Payments on deferred funding obligations 0 (18,791)
Net proceeds of common stock issuances 188,197 96,648
Payments of dividends and distributions (74,295) (64,239)
Withholdings on employee share vesting (17,287) (9,015)
Other (15,005) (8,304)
Net cash provided by (used in) financing activities 885,331 137,523
Increase (decrease) in cash, cash equivalents, and restricted cash 798,981 169,644
Cash, cash equivalents, and restricted cash at beginning of period 106,586 59,353
Cash, cash equivalents, and restricted cash at end of period 905,567 228,997
Interest paid 57,310 39,884
Non-cash changes in deferred funding obligations and non-recourse debt (financing activity) 0 (78,008)
Non-cash changes in receivables and investments (investing activity) 0 59,979
Non-cash changes in residual assets (investing activity) (38,081) (21,746)
Non-cash changes in escrow accounts (investing activity) $ 0 $ 18,029